CollPlant Biotechnologies (XTAE:CLGN) PB Ratio : 0.79 (As of May. 27, 2024)

View and export this data going back to 2007. Start your Free Trial

What is CollPlant Biotechnologies PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-27), CollPlant Biotechnologies's share price is ₪0.43. CollPlant Biotechnologies's Book Value per Share for the quarter that ended in Dec. 2023 was ₪0.54. Hence, CollPlant Biotechnologies's PB Ratio of today is 0.79.

The historical rank and industry rank for CollPlant Biotechnologies's PB Ratio or its related term are showing as below:

XTAE:CLGN' s PB Ratio Range Over the Past 10 Years
Min: 1.46 Med: 2.46 Max: 4.85
Current: 2.33

During the past 12 years, CollPlant Biotechnologies's highest PB Ratio was 4.85. The lowest was 1.46. And the median was 2.46.

XTAE:CLGN's PB Ratio is ranked better than
53.58% of 1312 companies
in the Biotechnology industry
Industry Median: 2.5 vs XTAE:CLGN: 2.33

During the past 12 months, CollPlant Biotechnologies's average Book Value Per Share Growth Rate was -14.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 56.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 28.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 24.00% per year.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of CollPlant Biotechnologies was 131.60% per year. The lowest was -30.00% per year. And the median was 24.25% per year.

Back to Basics: PB Ratio

CollPlant Biotechnologies PB Ratio Historical Data

The historical data trend for CollPlant Biotechnologies's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies PB Ratio Chart

CollPlant Biotechnologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

CollPlant Biotechnologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
PB Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of CollPlant Biotechnologies's PB Ratio

For the Biotechnology subindustry, CollPlant Biotechnologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CollPlant Biotechnologies's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's PB Ratio distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's PB Ratio falls into.

CollPlant Biotechnologies PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

CollPlant Biotechnologies's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	0.43	/	0.544
	=	0.79

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

CollPlant Biotechnologies (XTAE:CLGN) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

CollPlant Biotechnologies PB Ratio Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

CollPlant Biotechnologies (XTAE:CLGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (XTAE:CLGN) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

CLGN:USA CPT:Germany

Address

4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104

Website

https://www.collplant.com

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.